Brief: Aker BioMarine Q4 Adjusted EBITDA USD 17.6 Million Vs. IBES Estimate USD 20 Million
14/02/2024 06:00
Feb 14 (Reuters) - Aker BioMarine Q4 revenue USD 82.9 million vs. IBES estimate USD 88 million
Recent news on Aker Biomarine ASA
See all newsBrief: Aker Biomarine Secures Lysoveta Contract
Norway's Aker BioMarine Q1 revenue rises 13% on record krill oil sales
Brief: Aker Biomarine Q1 Adjusted EBITDA $12.5 Mln
Norway's Aker BioMarine exploring alternatives for Human Health Ingredient unit
Brief: Aker BioMarine Q4 Adjusted EBITDA USD 10.6 Million